Low impact
Eli Lilly reported higher net income and revenue in the recent quarter driven by continued strong demand for its GLP-1 weight-loss drugs.
WSJ08/05, 06:19 PM
Related assets
Coming up for LLY
Explore next
FirstSquawk08/05, 08:23 PM
Eli Lilly reports surging demand for GLP-1 weight-loss drugs.